CBD 101:

How Cannabis Bioavailability Changes Your High

mm
Add MyCannabis.com to your preferred sources on Google
Disclosure:

The content on MyCannabis.com is for educational purposes only and should not be taken as medical advice.

Editor’s Note: Our Masterclass series is supported by our readers. When you purchase through links on our site, we may earn an affiliate commission at no extra cost to you.

CBD Masterclass | Chapter 6.1: Bioavailability & Absorption
This article is a core module of the CBD Masterclass. Explore the full curriculum to master the science of cannabidiol.

When discussing the efficacy of cannabis, the conversation often centers on potency or percentages. However, one of the most critical factors influencing how cannabis affects the body is bioavailability. In technical terms, bioavailability is the rate and degree to which a substance enters systemic circulation and becomes available at the intended biological site of action.

Two individuals can consume the exact same milligram dose of cannabis and have fundamentally different experiences based on the delivery method. Whether a compound is inhaled, swallowed, or absorbed through mucous membranes dictates its onset time, intensity, and duration. Understanding these pathways is essential for transitioning from recreational use to intentional, therapeutic application.

Bioavailability Metrics by Method

Method Bioavailability Onset Time Duration Systemic Impact
Inhalation (Vaping) 10–35% 1–5 minutes 2–4 hours Immediate High
Oral (Edibles) 4–12% 30–120 minutes 6–8+ hours Delayed / Stronger
Topicals (Creams) Localized Only Minutes Varies Non-Intoxicating
Mucosal (Suppositories) 50–70% 15–45 minutes 4–8 hours High Absorption

Inhalation: The Rapid Pathway

Inhalation remains the fastest route of administration. When cannabis is inhaled, cannabinoids enter the bloodstream via the alveoli in the lungs. This bypasses the digestive tract and the liver entirely, allowing molecules to reach the brain within seconds. This makes inhalation ideal for addressing acute symptoms like sudden anxiety or breakthrough pain.

However, the bioavailability of smoking is hindered by combustion, which destroys a significant portion of the cannabinoids before they can be absorbed. Vaporization increases efficiency by using lower temperatures to preserve delicate terpenes and cannabinoids. Despite the speed, the duration is relatively short, usually dissipating within a few hours.

Bioavailability & Delivery Selection:

To optimize your results, choose a delivery method that aligns with your onset needs. We recommend the following brands for their high-efficiency delivery systems:

  • Acute Relief (Vapor): CBDfx and Koi CBD offer premium vape formulations designed for rapid-pathway bioavailability.
  • Standard Tinctures: Vena CBD provides refined oils that bridge the gap between mucosal speed and oral duration.

The Science of Oral Ingestion and First-Pass Metabolism

Oral ingestion—through capsules or edibles—presents the most complex biological journey. Once swallowed, cannabis must survive the acidic environment of the stomach before being absorbed in the small intestine. From there, it is transported via the portal vein to the liver. This is known as first-pass metabolism.

In the liver, enzymes such as CYP3A4 and CYP2C9 begin breaking down the cannabinoids. For THC, this results in a metabolic conversion into 11-hydroxy-THC. This metabolite is more potent and crosses the blood-brain barrier more readily than inhaled THC, which explains why edibles can feel significantly more intense despite having lower systemic bioavailability. Because this process is time-consuming, onset can take up to two hours, but the duration is much longer, providing sustained relief for chronic issues.

Topical vs. Transdermal Absorption

As discussed in our chapter on cannabis topicals, standard creams and salves do not enter the bloodstream. They offer localized bioavailability by interacting with the cutaneous endocannabinoid system. For systemic absorption through the skin, transdermal patches are required. These are formulated with penetration enhancers that allow cannabinoids to bypass the skin’s barrier and enter the capillary beds over an extended period.

Efficiency Spotlight: For high-concentration topical relief that targets localized receptors, Extract Labs Salves and Foria Botanicals lead the industry in skin-permeable formulations.

Mucosal Delivery: Suppositories and Tinctures

Mucosal administration involves absorbing cannabis through the thin membranes found under the tongue (sublingual) or in the rectal and vaginal cavities. This route is pharmacologically advantageous because it bypasses first-pass metabolism while offering much higher bioavailability than oral ingestion. Suppositories, in particular, allow for high doses of cannabis to be absorbed near localized areas of pelvic or gastrointestinal inflammation with minimal psychoactive interference.

Optimizing Your Results

Bioavailability is not about maximizing the “high,” but about maximizing the efficiency of the plant’s compounds. For many users, a combination of methods—such as an edible for baseline support and inhalation for acute needs—provides the most comprehensive results. By understanding how these delivery systems navigate your unique physiology, you can better tailor your cannabis routine to your specific health requirements.

In the next article, we explore how these compounds target the biological roots of discomfort: Chapter 7: CBD for Inflammation.

Explore the CBD Masterclass

This article is part of our comprehensive deep-dive into the science, history, and application of cannabidiol. From molecular biology to advanced dosage strategies, we analyze the evidence.

View the Full Masterclass Hub →

Sarah Schwefel is a journalist, research analyst, speaker, and patient advocate. After relocating for access to cannabis for her own health, she became engulphed in the cannabis and hemp industry determined to better help herself and other patients. In 2020, she became certified in endocannabinoid medicine studies from the American Journal of Endocannabinoid Medicine. Sarah uses her expertise to educate and advocate through her writing on various topics including legislation and the benefits plant medicine offers.